Norval M, Else R W, Maingay J
Department of Bacteriology, University of Edinburgh Medical School.
Res Vet Sci. 1988 Jan;44(1):76-81.
Tumours were induced in CBA athymic nude mice by subcutaneous injection of REM 134 cells. These cells were from a continuous line derived from a canine mammary carcinoma and have no detectable oestrogen receptors. In vitro, the anti-oestrogen tamoxifen was growth inhibitory at a concentration of 10(-6) M and adding 10(-8) M oestradiol-17 beta did not reverse this effect. The relative rate of growth of the tumours induced by the cultured cells was the same in male and female mice. Oral tamoxifen at a dose of 1 mg mouse-1 week-1 suppressed the early growth rate significantly and to the same extent in male and female mice; conversely subcutaneous tamoxifen at 2 mg mouse-1 week-1 had only a transient early effect. These results argue against tamoxifen acting solely as an antagonist for oestrogen.
通过皮下注射REM 134细胞在CBA无胸腺裸鼠中诱导肿瘤。这些细胞来源于犬乳腺癌的连续细胞系,且未检测到雌激素受体。在体外,抗雌激素他莫昔芬在浓度为10(-6) M时具有生长抑制作用,添加10(-8) M的17β-雌二醇并不能逆转这种作用。培养细胞诱导的肿瘤在雄性和雌性小鼠中的相对生长速率相同。剂量为1 mg/小鼠/周的口服他莫昔芬显著抑制了早期生长速率,且在雄性和雌性小鼠中抑制程度相同;相反,剂量为2 mg/小鼠/周的皮下注射他莫昔芬仅具有短暂的早期作用。这些结果表明他莫昔芬并非仅作为雌激素拮抗剂发挥作用。